天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

返回ChemicalBook首頁>CAS數(shù)據(jù)庫列表>178961-24-5

178961-24-5

中文名稱 264W 94
CAS 178961-24-5
分子式 C23H31NO4S
分子量 417.56
MOL 文件 178961-24-5.mol
178961-24-5 結(jié)構(gòu)式 178961-24-5 結(jié)構(gòu)式

基本信息

英文別名
264W 94

常見問題列表

生物活性
264W94 是有效的回腸膽汁酸轉(zhuǎn)運蛋白 (IBAT) 抑制劑,是新型降膽固醇藥。264W94 具有 CYP7A1 誘導(dǎo)作用和抗血脂作用。
靶點

IBAT

體外研究

264W94 (0, 0.1, 0.25, 0.5 μM) inhibits human IBAT-specific transport of 5 μM TC by 14% to 75% in a concentration-dependent manner with IC 50 of 0.25 μM in CHO-hIBAT cells.

體內(nèi)研究

264W94 (orally; 0.03-1.0 mg/kg; twice a day for 3.5 days) dose-dependently attenuates diet-induced increases in serum LDL+VLDL-C, as well as the decrease in HDL-C.
264W94 (orally; 0.003, 0.01, 0.03, 0.1 mg/kg; twice a day for 2 days) increases fecal excretion of 75 SeHCAT in a dose-dependent manner.
264W94 (0.001, 0.01, 0.1, 1, and 10 mg/kg; twice a day for 2 weeks) reduces dose-dependently plasma glucose in male ZDF (ZDF/GmiCrl- fa/fa ) rats. Treatment of 264W94 prevents the decline of insulin dose-dependently without an increase in proinsulin levels.

Animal Model: Male Sprague Dawley rats (CD, Charles River, 270-310 gm)
Dosage: 0.03, 0.1, 0.3, 1.0 mg/kg
Administration: Orally; twice a day (9:00 am and 3:30 pm) for 3.5 days
Result: Dose-dependently attenuated diet-induced increases in serum LDL+VLDL-C, as well as the decrease in HDL-C.
"178961-24-5" 相關(guān)產(chǎn)品信息